Citadel Advisors
SBCWW icon

Citadel Advisors’s SBC Medical Group Warrants SBCWW Stock Holding History

Citadel Advisors’s Portfolio SBCWW Stock Details SBCWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11,080
Closed -$568 – 15421
2023
Q3 		$568 Buy
+11,080
New +$589 ﹤0.01% 14024
2023
Q1 		– Sell
-15,816
Closed -$871 – 15660
2022
Q4 		$871 Sell
15,816
-41,998
-73% -$1.95K ﹤0.01% 14567
2022
Q3 		$6K Buy
+57,814
New +$4.81K ﹤0.01% 12354

Other funds holding SBCWW

Mangrove Partners
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
Boothbay Fund Management
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Polar Asset Management Partners
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Shaolin Capital Management
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
Context Capital Management
Context Capital Management Lajolla, California $4.89B AUM 1.86% 1-Year Est. Return
Schechter Investment Advisors
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
AQR Arbitrage
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Taconic Capital Advisors
Taconic Capital Advisors New York $212M AUM 100.15% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
Periscope Capital
Periscope Capital Toronto, Ontario, Canada $990M AUM 4.73% 1-Year Est. Return

Citadel Advisors's SBCWW Position: Q4 2023 in Review

Citadel Advisors sold out of SBC Medical Group Warrants (SBCWW) in Q4 2023, closing a stake of 11,080 shares — an estimated $568 sold.

Citadel Advisors first reported a position in SBCWW in Q3 2022 and held it in 3 quarters. The position peaked at $6K in Q3 2022. 31 funds tracked by Wall St. Rank hold SBCWW as of Q4 2023.

  • Citadel Advisors reported no remaining SBC Medical Group Warrants position as of Q4 2023 after selling out during the quarter.
  • Citadel Advisors sold 11,080 SBC Medical Group Warrants shares in Q4 2023, an estimated $568.
  • Citadel Advisors first reported a position in SBC Medical Group Warrants in Q3 2022 and held it in 3 quarters.
  • Citadel Advisors's SBC Medical Group Warrants position peaked at $6K in Q3 2022.
  • 31 funds tracked by Wall St. Rank held SBC Medical Group Warrants as of Q4 2023.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.